The company also operates two finished pharmaceutical formulation plants in Goa, which are highly efficient in design and output, with vast manufacturing capacity. In the past year, the Goa plants have manufactured 150 licensed generic and specialty medicines, with 6.1 billion pharmaceutical dosage units produced. Both the manufacturing plants adhere to applicable Good Manufacturing Practices (GMP) and are audited by various regulatory agencies and ministries.